Development and use of ceramide nanoliposomes in cancer

Methods in Enzymology

Volumn 508, Issue , 2012, Pages 89-108

  Watters, Rebecca J ^a   Kester, Mark ^a,b   Tran, Melissa A ^b   Loughran, Thomas P ^a   Liu, Xin ^a  

^a PENN STATE CANCER INSTITUTE   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Cancer therapy; Ceramide; Nanoliposome; Pegylation; Sphingolipids

Indexed keywords

CERAMIDE; LIPOSOME; MELANOCYTE PROTEIN PMEL 17; NANOLIPOSOME; NANOPARTICLE; REACTIVE OXYGEN METABOLITE; SORAFENIB; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL CYCLE ARREST; CELL DEATH; CELL VIABILITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA; LIPID METABOLISM; MALE; MAXIMUM TOLERATED DOSE; MELANOMA; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NANOMEDICINE; NONHUMAN; PRIORITY JOURNAL; RAT; SECOND MESSENGER; ZETA POTENTIAL;

EID: 84859094221     PISSN: 00766879     EISSN: 15577988     Source Type: Book Series    
DOI: 10.1016/B978-0-12-391860-4.00005-7     Document Type: Chapter

References (43)

1. L. Aagaard, and J.J. Rossi RNAi therapeutics: Principles, prospects and challenges Adv. Drug Deliv. Rev. 59 2007 75 86 (Pubitemid 46770900)
2. B.M. Barth, M.C. Cabot, and M. Kester Ceramide-based therapeutics for the treatment of cancer Anticancer Agents Med. Chem. 11 9 2011 911 919
3. H. Birbes, S. El Bawab, L.M. Obeid, and Y.A. Hannun Mitochondria and ceramide: Intertwined roles in regulation of apoptosis Adv. Enzyme Regul. 42 2002 113 129 (Pubitemid 35033533)
4. L.A. Carver, and J.E. Schnitzer Caveolae: Mining little caves for new cancer targets Nat. Rev. Cancer 3 2003 571 581 (Pubitemid 37328829)
5. A.E. Cremesti, F.M. Goni, and R. Kolesnick Role of sphingomyelinase and ceramide in modulating rafts: Do biophysical properties determine biologic outcome? FEBS Lett. 531 2002 47 53 (Pubitemid 35232783)
6. W.H. De Jong, and P.J. Borm Drug delivery and nanoparticles:Applications and hazards Int. J. Nanomedicine 3 2008 133 149
7. A. Desai, T. Vyas, and M. Amiji Cytotoxicity and apoptosis enhancement in brain tumor cells upon coadministration of paclitaxel and ceramide in nanoemulsion formulations J. Pharm. Sci. 97 2008 2745 2756
8. H. Devalapally, Z. Duan, M.V. Seiden, and M.M. Amiji Paclitaxel and ceramide co-administration in biodegradable polymeric nanoparticulate delivery system to overcome drug resistance in ovarian cancer Int. J. Cancer 121 2007 1830 1838 (Pubitemid 47417304)
9. H. Devalapally, Z. Duan, M.V. Seiden, and M.M. Amiji Modulation of drug resistance in ovarian adenocarcinoma by enhancing intracellular ceramide using tamoxifen-loaded biodegradable polymeric nanoparticles Clin. Cancer Res. 14 2008 3193 3203
10. M. Di Paola, T. Cocco, and M. Lorusso Ceramide interaction with the respiratory chain of heart mitochondria Biochemistry 39 2000 6660 6668 (Pubitemid 30353998)
11. J.A. Ellerhorst, A. Bedikian, S. Ring, A.C. Buzaid, O. Eton, and S.S. Legha Phase II trial of doxil for patients with metastatic melanoma refractory to frontline therapy Oncol. Rep. 6 1999 1097 1099
12. H. Farhood, N. Serbina, and L. Huang The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer Biochim. Biophys. Acta 1235 1995 289 295
13. C.M. Finnegan, S.S. Rawat, A. Puri, J.M. Wang, F.W. Ruscetti, and R. Blumenthal Ceramide, a target for antiretroviral therapy Proc. Natl. Acad. Sci. USA 101 2004 15452 15457 (Pubitemid 39441562)
14. A. Gabizon, and F. Martin Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumours Drugs 54 Suppl. 4 1997 15 21 (Pubitemid 27487791)
15. C. Garcia-Ruiz, A. Colell, M. Mari, A. Morales, and J.C. Fernandez-Checa Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. Role of mitochondrial glutathione J. Biol. Chem. 272 1997 11369 11377 (Pubitemid 27184141)
16. A. Haimovitz-Friedman, C.C. Kan, D. Ehleiter, R.S. Persaud, M. McLoughlin, Z. Fuks, and R.N. Kolesnick Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis J. Exp. Med. 180 1994 525 535 (Pubitemid 24224129)
17. L.S. Ihrlund, E. Hernlund, O. Khan, and M.C. Shoshan 3-Bromopyruvate as inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs Mol. Oncol. 2 2008 94 101
18. Y. Jiang, N.A. Divittore, J.M. Kaiser, S.S. Shanmugavelandy, J.L. Fritz, Y. Heakal, H.R. Tagaram, H. Cheng, M.C. Cabot, K.F. Staveley-O'Carroll, M.A. Tran, and T.E. Fox Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer Cancer Biol. Ther. 12 2011 574 585
19. S. Karahatay, K. Thomas, S. Koybasi, C.E. Senkal, S. Elojeimy, X. Liu, J. Bielawski, T.A. Day, M.B. Gillespie, D. Sinha, J.S. Norris, Y.A. Hannun, and B. Ogretmen Clinical relevance of ceramide metabolism in the pathogenesis of human head and neck squamous cell carcinoma (HNSCC): Attenuation of C(18)-ceramide in HNSCC tumors correlates with lymphovascular invasion and nodal metastasis Cancer Lett. 256 2007 101 111 (Pubitemid 47333333)
20. E. Khazanov, A. Priev, J.P. Shillemans, and Y. Barenholz Physicochemical and biological characterization of ceramide-containing liposomes: Paving the way to ceramide therapeutic application Langmuir 24 2008 6965 6980
21. R.N. Kolesnick, and M. Kronke Regulation of ceramide production and apoptosis Annu. Rev. Physiol. 60 1998 643 665
22. X. Liu, L. Ryland, J. Yang, A. Liao, C. Aliaga, R. Watts, S.F. Tan, J. Kaiser, S.S. Shanmugavelandy, A. Rogers, K. Loughran, and B. Petersen Targeting of survivin by nanoliposomal ceramide induces complete remission in a rat model of NK-LGL leukemia Blood 116 2010 4192 4201
23. A.H. Merrill Jr., and D.D. Jones An update of the enzymology and regulation of sphingomyelin metabolism Biochim. Biophys. Acta 1044 1990 1 12 (Pubitemid 20144101)
24. M.C. Messner, and M.C. Cabot Glucosylceramide in humans Adv. Exp. Med. Biol. 688 2010 156 164
25. T.T. Morgan, H.S. Muddana, E.I. Altinoglu, S.M. Rouse, A. Tabakovic, T. Tabouillot, T.J. Russin, S.S. Shanmugavelandy, P.J. Butler, P.C. Eklund, J.K. Yun, and M. Kester Encapsulation of organic molecules in calcium phosphate nanocomposite particles for intracellular imaging and drug delivery Nano Lett. 8 2008 4108 4115
26. NCL T.R. NCL Technical Reports 2007 NCL200702A
27. N.S. Radin Killing cancer cells by poly-drug elevation of ceramide levels: A hypothesis whose time has come? Eur. J. Biochem. 268 2001 193 204 (Pubitemid 32862649)
28. L.K. Ryland, T.E. Fox, X. Liu, T.P. Loughran, and M. Kester Dysregulation of sphingolipid metabolism in cancer Cancer Biol. Ther. 11 2011 138 149
29. S.A. Saddoughi, P. Song, and B. Ogretmen Roles of bioactive sphingolipids in cancer biology and therapeutics Düzgüne Biochem. 49 2008 413 440
30. I.I. Salem, D.L. Flasher, and N. Düzgüne Liposome-encapsulated antibiotics Methods Enzymol. 391 2005 261 291 (Pubitemid 40254040)
31. S. Schiffmann, J. Sandner, K. Birod, I. Wobst, C. Angioni, E. Ruckhaberle, M. Kaufmann, H. Ackermann, J. Lotsch, H. Schmidt, G. Geisslinger, and S. Grosch Ceramide synthases and ceramide levels are increased in breast cancer tissue Carcinogenesis 30 2009 745 752
32. F. Schroeder, A.M. Gallegos, B.P. Atshaves, S.M. Storey, A.L. McIntosh, A.D. Petrescu, H. Huang, O. Starodub, H. Chao, H. Yang, A. Frolov, and A.B. Kier Recent advances in membrane microdomains: Rafts, caveolae, and intracellular cholesterol trafficking Exp. Biol. Med. (Maywood) 226 2001 873 890
33. J.A. Shabbits, and L.D. Mayer High ceramide content liposomes with in vivo antitumor activity Anticancer Res. 23 2003 3663 3669 (Pubitemid 37474309)
34. J.A. Shabbits, and L.D. Mayer Intracellular delivery of ceramide lipids via liposomes enhances apoptosis in vitro Biochim. Biophys. Acta 1612 2003 98 106 (Pubitemid 36555692)
35. T. Stover, and M. Kester Liposomal delivery enhances short-chain ceramide-induced apoptosis of breast cancer cells J. Pharmacol. Exp. Ther. 307 2003 468 475 (Pubitemid 37310658)
36. T.C. Stover, A. Sharma, G.P. Robertson, and M. Kester Systemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinoma Clin. Cancer Res. 11 2005 3465 3474 (Pubitemid 40627901)
37. T.C. Stover, Y.S. Kim, T.L. Lowe, and M. Kester Thermoresponsive and biodegradable linear-dendritic nanoparticles for targeted and sustained release of a pro-apoptotic drug Biomaterials 29 2008 359 369 (Pubitemid 350081048)
38. H.R. Tagaram, N.A. Divittore, B.M. Barth, J.M. Kaiser, D. Avella, E.T. Kimchi, Y. Jiang, H.C. Isom, M. Kester, and K.F. Staveley-O'Carroll Nanoliposomal ceramide prevents in vivo growth of hepatocellular carcinoma Gut 60 2011 695 701
39. Y. Tokudome, Y. Saito, F. Sato, M. Kikuchi, T. Hinokitani, and K. Goto Preparation and characterization of ceramide-based liposomes with high fusion activity and high membrane fluidity Colloids Surf. B Biointerfaces 73 2009 92 96
40. M.A. Tran, C.D. Smith, M. Kester, and G.P. Robertson Combining nanoliposomal ceramide with sorafenib synergistically inhibits melanoma and breast cancer cell survival to decrease tumor development Clin. Cancer Res. 14 2008 3571 3581
41. M.A. Tran, R.J. Watts, and G.P. Robertson Use of liposomes as drug delivery vehicles for treatment of melanoma Pigment Cell Melanoma Res. 22 2009 388 399
42. L.E. van Vlerken, T.K. Vyas, and M.M. Amiji Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery Pharm. Res. 24 2007 1405 1414 (Pubitemid 46988224)
43. B.S. Zolnik, S.T. Stern, J.M. Kaiser, Y. Heakal, J.D. Clogston, M. Kester, and S.E. McNeil Rapid distribution of liposomal short-chain ceramide in vitro and in vivo Drug Metab. Dispos. 36 2008 1709 1715